Case Report: A rare case of CD20-positive T-cell large granular lymphocyte leukemia with renal cell carcinoma: a challenging diagnosis
暂无分享,去创建一个
Y. Jin | Ying-Hua Wu | Shuyan Wang | Jin Xu | Jianfeng Xu | F. Ren | Jin-fen Tang
[1] R. Zambello,et al. Not all LGL leukemias are created equal. , 2023, Blood reviews.
[2] A. Órfão,et al. Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients , 2022, Blood.
[3] A. Rosenwald,et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.
[4] E. Giné,et al. Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution , 2021, Cancers.
[5] Q. Mo,et al. Large granular lymphocytic leukemia – A retrospective study of 319 cases , 2021, American journal of hematology.
[6] Cui Zhang,et al. CD20‐positive primary nasal peripheral T‐cell lymphoma: An analysis of one case and review of the literature , 2020, Cytometry. Part B, Clinical cytometry.
[7] T. Loughran,et al. Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia , 2020, Current Hematologic Malignancy Reports.
[8] A. Frigo,et al. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients , 2019, Leukemia.
[9] Jian-yong Li,et al. T-cell large granular lymphocytic leukemia associated with renal cell carcinoma , 2018, Medicine.
[10] J. Maciejewski,et al. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL) , 2018, Leukemia & lymphoma.
[11] T. Loughran,et al. LGL leukemia: from pathogenesis to treatment. , 2017, Blood.
[12] S. Bortoluzzi,et al. High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia. , 2016, Blood.
[13] K. Ohshima,et al. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review , 2015, International Journal of Hematology.
[14] J. Maciejewski,et al. High rate of both hematopoietic and solid tumors associated with large granular lymphocyte leukemia , 2015, Leukemia & lymphoma.
[15] S. Mustjoki,et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. , 2012, The New England journal of medicine.
[16] S. Jeon,et al. CD20 Positive T Cell Lymphoma Involvement of Skin , 2011, Annals of dermatology.
[17] M. Wlodarski,et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. , 2011, Blood.
[18] T. Loughran,et al. How I treat LGL leukemia. , 2011, Blood.
[19] T. Fest,et al. Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases , 2010, Haematologica.
[20] Wong-Ho Chow,et al. Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.
[21] J. Maciejewski,et al. Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia , 2009, Current opinion in hematology.
[22] J. Maciejewski,et al. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. , 2008, Experimental Hematology.
[23] Y. Hosokawa,et al. CD20- and CD56-Positive T-Cell Large Granular Lymphocyte Leukemia in a Human T-Cell Leukemia Virus Type 1 Carrier , 2007, International journal of hematology.
[24] T. Molina,et al. Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2007, Leukemia.
[25] S. Perkins,et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. , 2005, American journal of clinical pathology.
[26] C. O'keefe,et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. , 2005, Blood.
[27] V. Janout,et al. Epidemiology and risk factors of kidney cancer. , 2004, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[28] T. Braun,et al. CD20 positive T cell lymphoma: is it a real entity? , 2004, Journal of Clinical Pathology.
[29] C. O'keefe,et al. Molecular Analysis of TCR Clonotypes in LGL: A Clonal Model for Polyclonal Responses1 , 2004, The Journal of Immunology.
[30] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[31] Ana Helena Santos,et al. TCRαβ+/CD4+ Large Granular Lymphocytosis: A New Clonal T-Cell Lymphoproliferative Disorder , 2003 .
[32] K. Sugimoto,et al. CD3‐negative, CD20‐positive T‐cell prolymphocytic leukemia: Case report and review of the literature , 2002, American journal of hematology.
[33] E. Squiers,et al. Large granular lymphocyte leukaemia occurring after renal transplantation , 1998, British journal of haematology.
[34] K. Akashi,et al. Large granular lymphocytic leukaemia with a mixed T‐cell/B‐cell phenotype , 1998, British journal of haematology.
[35] K. Groeneveld,et al. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vβ antibodies , 1998, Leukemia.
[36] F. Craig,et al. CD20 (pan-B cell antigen) expression on bone marrow-derived T cells. , 1996, American journal of clinical pathology.
[37] Y. Murayama,et al. Transient Expression of CD20 Antigen (Pan B Cell Marker) in Activated Lymph Node T Cells , 1996, Microbiology and immunology.
[38] N. Harris,et al. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. , 1994, American journal of clinical pathology.
[39] M. Dhodapkar,et al. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? , 1994, Blood.
[40] T. Loughran,et al. Clonal diseases of large granular lymphocytes. , 1993, Blood.
[41] T. Loughran,et al. Evaluation of splenectomy in large granular lymphocyte leukaemia , 1987, British journal of haematology.
[42] R. Advani,et al. Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision of the World Health Organization classi fi cation of lymphoid neoplasms , 2016 .
[43] K. Ohshima,et al. Six Cases of CD20-Positive Adult T-Cell Leukemia. , 2016, Journal of clinical and experimental hematopathology : JCEH.
[44] R. Advani,et al. The World Health Organization Classification of Lymphoid Neoplasms , 2013 .
[45] M. Higashihara,et al. CD20-positive T-cell large granular lymphocyte leukemia: case report and review of the literature. , 2009, Internal medicine.
[46] K. Hongo,et al. A case report and review of the literature , 2006, Journal of Neuro-Oncology.
[47] Ana Helena Santos,et al. TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder. , 2003, The American journal of pathology.
[48] D. Oscier,et al. Lymphoid neoplasms. , 2001, Baillière's Best Practice & Research: Clinical Haematology.
[49] D. C. Henckel,et al. Case report. , 1995, Journal.
[50] J. Giorgi,et al. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes. , 1993, Cytometry.